| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2006, Vol. 107, No. 3, pp. 1217-1219. Prepublished online as a Blood First Edition Paper on October 6, 2005; DOI 10.1182/blood-2005-04-1744.
TRANSFUSION MEDICINE Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung modelFrom the Institute for Clinical Immunology and Transfusion Medicine, Department of Internal Medicine, and the Department of Pathology, Justus Liebig University, Giessen, Germany; Rudolf Virchow Center for Experimental Biomedicine, Wuerzburg, Germany; and the German Red Cross Blood Service West, Hagen, Germany.
Transfusion-related acute lung injury (TRALI) is a hazardous complication of transfusion and has become the leading cause of transfusion-related death in the United States and United Kingdom. Although leukoagglutinating antibodies have been frequently shown to be associated with the syndrome, the mechanism by which they induce TRALI is poorly understood. Therefore, we reproduced TRALI in an ex vivo rat lung model. Our data demonstrate that TRALI induction by antileukocyte antibodies is dependent on the density of the cognate antigen but does not necessarily require leukoagglutinating properties of the antibody or the presence of complement proteins. Rather, antibody-mediated activation of neutrophils seems to initiate TRALI, a process that could be triggered by neutrophil stimulation with fMLP. Antibody-mediated neutrophil activation and subsequent release of reactive oxygen species may thus represent key events in the pathophysiologic cascade that leads to immune TRALI.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||